Patent Assignment
Reel/Frame 061292/0778
Assignment of Assignor's Interest
Recorded: 2022-10-03
Pages: 3
Assignor
CYDEX PHARAMACEUTICALS, INC.
Executed: 2009-07-27
Assignee
PRISM PHARMACEUTICALS, INC.
1150 FIRST AVENUE, SUITE 1050, KING OF PRUSSIA, PENNSYLVANIA, 19406
Covered Property
(1)
Formulations Containing Clopidogrel and Sulfoalkyl Ether Cyclodextrin and Methods of Use
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 3, 2022
From: WEDEL, REBECCA L.; JOHNSON, KAREN T.; MACHATHA, STEPHEN G.; COWEE, JANE A.
To: CYDEX PHARMACEUTICALS, INC.
Reel/Frame 061292/0690 →
Assignment of Assignor's Interest
Oct 3, 2022
From: CUSHING, DANIEL J.
To: PRISM PHARMACEUTICALS, INC.
Reel/Frame 061292/0820 →
Security Interest
Oct 18, 2023
From: CYDEX PHARMACEUTICALS, INC.; LIGAND PHARMACEUTICALS INCORPORATED; METABASIS THERAPEUTICS, INC.; PFENEX INC.
To: CITIBANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 065271/0025 →
Corrective Assignment to Correct the Assignor (Conveying) and Assignee (Receiving) Switched. Correct Should Be Prism to Cydex. Previously Recorded on Reel 61292 Frame 778. Assignor(S) Hereby Confirms the Assignment.
Aug 6, 2025
From: PRISM PHARMACEUTICALS, INC.
To: CYDEX PHARMACEUTICALS, INC.
Reel/Frame 072372/0047 →